Drug intelligence / Profile preview

2'-fucosyllactose

Development stage
Phase 2
Lead developer
Chr. Hansen
Modality
Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
Administration
Oral
01

Overview

2'-Fucosyllactose (2'-FL) is a fucosylated neutral trisaccharide composed of L-fucose, D-galactose, and D-glucose units. It is the most prevalent human milk oligosaccharide (HMO), naturally present in human breast milk and making up about 30% of all HMOs[4]. It is produced commercially via microbial fermentation using E. coli or by chemical/enzymatic synthesis[4][8][6]. As a prebiotic compound, it promotes the growth of beneficial bifidobacteria in the gut and helps protect against infectious diseases by preventing pathogen adhesion to epithelial cells[4]. In addition to its prebiotic effects, studies suggest anti-inflammatory properties and potential immune-enhancing effects through modulation of cytokine production such as IL-10 and IFN-gamma[1][5]. Clinical trials are investigating its use as a dietary supplement for conditions like inflammatory bowel disease (IBD)[3].

Brand names
PREBILAC
Other names
2′-FLhuman milk oligosaccharideHMOfucosylated neutral trisaccharide

Beyond the preview

Go deeper on 2'-fucosyllactose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2'-fucosyllactose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call